Krzysztof Grzymajlo

Dr. Krzysztof Grzymajlo

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in Gut Microbes
Verified
Journal Article
Open access
AAAdrianna Aleksandrowicz
Adrianna Aleksandrowicz
ECEwa Carolak
Ewa Carolak
ADAgata Dutkiewicz
Agata Dutkiewicz
ABAleksandra Błachut
Aleksandra Błachut
WWWiktoria Waszczuk
Wiktoria Waszczuk
KGKrzysztof Grzymajlo
Krzysztof Grzymajlo
Salmonella poses a serious threat to public health and socioeconomic development worldwide because of its foodborne pathogenicity and antimicrobial resistance. This biofilm-planktonic lifestyle enables Salmonella to interfere with the host and become resistant to drugs, conferring inherent tolerance to antibiotics. The complex biofilm structure makes bacteria tolerant to harsh conditions due to the diversity of physiological, biochemical, environmental, and molecular factors constituting resistance mechanisms. Here, we provide an overview of the mechanisms of Salmonella biofilm formation and antibiotic resistance, with an emphasis on less-studied molecular factors and in-depth analysis of the latest knowledge about upregulated drug-resistance-associated genes in bacterial aggregates. We classified and extensively discussed each group of these genes encoding transporters, outer membrane proteins, enzymes, multiple resistance, metabolism, and stress response-associated proteins. Finally, we highlighted the missing information and studies that need to be undertaken to understand biofilm features and contribute to eliminating antibiotic-resistant and health-threatening biofilms.

14 May 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
RKRafał Kolenda
Rafał Kolenda
MUMaciej Ugorski
Maciej Ugorski
KGKrzysztof Grzymajlo
Krzysztof Grzymajlo
Initial attachment to host intestinal mucosa after oral infection is one of the most important stages during bacterial pathogenesis. Adhesive structures, widely present on the bacterial surface, are mainly responsible for the first contact with host cells and of host-pathogen interactions. Among dozens of different bacterial adhesins, type 1 fimbriae (T1F) are one of the most common adhesive organelles in the members of the Enterobacteriaceae family, including Salmonella spp., and are important virulence factors. Those long, thin structures, composed mainly of FimA proteins, are responsible for recognizing and binding high-mannose oligosaccharides, which are carried by various glycoproteins and expressed at the host cell surface, via FimH adhesin, which is presented at the top of T1F. In this review, we discuss investigations into the functions of T1F, from the earliest work published in 1958 to operon organization, organelle structure, T1F biogenesis, and the various functions of T1F in Salmonella-host interactions. We give special attention to regulation of T1F expression and their role in binding of Salmonella to cells, cell lines, organ explants, and other surfaces with emphasis on biofilm formation and discuss T1F role as virulence factors based on work using animal models. We also discuss the importance of allelic variation in fimH to Salmonella pathogenesis, as well as role of FimH in Salmonella host specificity.

7 June 2012 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
DKDagmara I Kisiela
Dagmara I Kisiela
SCSujay Chattopadhyay
Sujay Chattopadhyay
SLStephen J Libby
Stephen J Libby
JKJoyce E Karlinsey
Joyce E Karlinsey
FFFerric C Fang
Ferric C Fang
ESEvgeni V Sokurenko
Evgeni V Sokurenko
Whereas the majority of pathogenic Salmonella serovars are capable of infecting many different animal species, typically producing a self-limited gastroenteritis, serovars with narrow host-specificity exhibit increased virulence and their infections frequently result in fatal systemic diseases. In our study, a genetic and functional analysis of the mannose-specific type 1 fimbrial adhesin FimH from a variety of serovars of Salmonella enterica revealed that specific mutant variants of FimH are common in host-adapted (systemically invasive) serovars. We have found that while the low-binding shear-dependent phenotype of the adhesin is preserved in broad host-range (usually systemically non-invasive) Salmonella, the majority of host-adapted serovars express FimH variants with one of two alternative phenotypes: a significantly increased binding to mannose (as in S. Typhi, S. Paratyphi C, S. Dublin and some isolates of S. Choleraesuis), or complete loss of the mannose-binding activity (as in S. Paratyphi B, S. Choleraesuis and S. Gallinarum). The functional diversification of FimH in host-adapted Salmonella results from recently acquired structural mutations. Many of the mutations are of a convergent nature indicative of strong positive selection. The high-binding phenotype of FimH that leads to increased bacterial adhesiveness to and invasiveness of epithelial cells and macrophages usually precedes acquisition of the non-binding phenotype. Collectively these observations suggest that activation or inactivation of mannose-specific adhesive properties in different systemically invasive serovars of Salmonella reflects their dynamic trajectories of adaptation to a life style in specific hosts. In conclusion, our study demonstrates that point mutations are the target of positive selection and, in addition to horizontal gene transfer and genome degradation events, can contribute to the differential pathoadaptive evolution of Salmonella. The process of Salmonella host-adaptation is traditionally considered to involve acquisition of novel genetic elements encoding specific virulence factors or loss of genes representing liability for the more pathogenic strains. Here, by analysis of the mannose-sensitive fimbrial adhesin FimH, we demonstrate that in addition to horizontal gene transfer and genome degradation, single amino acid replacement plays an important role in the differential adaptive evolution of Salmonella. We show that acquisition of specific structural mutations in FimH variants of host-adapted (systemically invasive) serovars results in either significantly enhanced or, alternatively, completely inactivated mannose-binding, whereas systemically non-invasive serovars retain a primordial relatively low-binding (shear-dependent) phenotype. A phylogenetic analysis indicates that these mutations are commonly of a convergent nature and occur under strong positive selection illustrating the role of point amino acid changes in convergent evolution of host-adapted Salmonella. Although we show increased bacterial adhesiveness and cell-invasiveness of the high-binding mutants, the physiologic role of the non-binding mutations in FimH remains to be determined.

9 April 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
MKMarta Kuźmińska-Bajor
Marta Kuźmińska-Bajor
KGKrzysztof Grzymajlo
Krzysztof Grzymajlo
MUMaciej Ugorski
Maciej Ugorski
We have recently shown that S. Gallinarum type 1 fimbriae with endogenous mannose-resistant (MR) variant of the FimH protein increase systemic dissemination of S. Gallinarum and colonization of internal organs in comparison to the S. Gallinarum fimH knockout strain or the mutant expressing mannose-sensitive (MS) FimH variant from S. Enteritidis. Elaborating from these studies, we proposed that MS variants of FimH are advantageous in gastrointestinal infections, in contrast to MR FimH variants which decrease intestinal colonization and promote their systemic spreading. To support our hypothesis, we carried out in vivo studies using mice infected with wild type S. Enteritidis and its fimH knockout strain (S.Enteritidis fimH::kan), which was characterized by significantly lower adhesion and invasiveness of murine ICE-1 intestinal cells. Using bioluminescence imaging, we observed that the loss of MS FimH adhesin correlates well with the highly increased colonization of mice by these bacteria. The appearance of the mutant strain was observed much earlier than wild-type Salmonella, and mice infected with 104–107 S.Enteritidis fimH::kan CFUs had significantly (P<0.05) shorter infection-free time than animals inoculated with wild type S. Enteritidis. Infections caused by non-typhoid Salmonella, such as S. Enteritidis, are associated with massive inflammation of the lamina propria and lymph nodes in the intestinal tract. Therefore, we evaluated the role of MS type 1 fimbriae in the induction of cytokine expression and secretion, using murine ICE-1 intestinal cells. We showed that the expression, as well as secretion, of Il-1B, Il-6, Il-10 and Il-12b was significantly higher in cells infected with wild type S. Enteritidis compared to cells infected with the mutant strain. Based on our results, we propose that type 1 fimbriae may play an important role in the pathogenicity of S. Enteritidis and may contribute to an intestinal inflammatory response.

18 June 2025 in Gut Microbes
Verified
Journal Article
Open access
ECEwa Carolak
Ewa Carolak
JCJoanna Czajkowska
Joanna Czajkowska
ASAdrianna Stypułkowska
Adrianna Stypułkowska
WWWiktoria Waszczuk
Wiktoria Waszczuk
ADAgata Dutkiewicz
Agata Dutkiewicz
KGKrzysztof Grzymajlo
Krzysztof Grzymajlo
Intestinal pathogens pose a significant global health burden, and traditional antibiotic treatments often disrupt the beneficial gut microbiota that plays a crucial role in maintaining host health through pathogen prevention and immune regulation. Although probiotics have emerged as promising therapeutic agents, their efficacy is limited by strain-dependent variations, survival challenges in the gastrointestinal tract, and inconsistent immune responses. Recent advances in genetic engineering, particularly CRISPR-Cas systems and their combinations with complementary technologies, such as Cre-lox and RecE/T, have enabled the precise modification of probiotic strains to enhance their therapeutic potential. These enhanced probiotics demonstrate improved functionality through multiple mechanisms, including increased adhesion via the expression of specific proteins (InlA, FnBPA, and LAP), targeted antimicrobial activity through engineered sensing systems (Lactococcus lactis detecting Vibrio cholerae CAI-1), and enhanced immunomodulation through cytokine production. Results have demonstrated the potential of genetically modified probiotics in preventing and treating gastrointestinal infections through mechanisms that include competitive exclusion, bacteriocin production, intestinal barrier reinforcement, and immune modulation. However, challenges remain in ensuring genetic stability and preventing horizontal gene transfer. Future research should focus on optimizing probiotic strains for targeted applications while addressing biosafety concerns. By understanding the complex interplay between probiotics, pathogens, and host immunity, innovative strategies can be developed to harness the full therapeutic potential of probiotic interventions in maintaining gut health.